Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
HitGen has successfully completed a three-year collaboration with MTPC to discover novel hit compounds for multiple drug targets
2022-02-25 10:00
Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer
2022-02-24 13:34
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China
2022-02-24 10:32
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement
2022-02-23 23:00
SyMap Medical Ltd Completed Enrollment in SMART Study for the Treatment of Uncontrolled Hypertension
2022-02-23 21:00
Simcere Pharma (2096.HK) Announces a Positive Profit Alert
2022-02-23 16:22
InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP
2022-02-22 17:09
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow
2022-02-22 16:38
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer
2022-02-21 22:00
Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development
2022-02-21 22:00
Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2)in Frontiers in Immunology
2022-02-21 21:00
Keymed Bio Joins Hang Seng Family of Indexes
2022-02-18 22:10
TransThera Announces that the IND Application of TT-01488, a Non-covalent Reversible BTK Inhibitor, for the Treatment of B-Cell Lymphomas has been Approved by the FDA in the US and Officially Accepted by the NMPA in China
2022-02-18 22:00
PolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology
2022-02-18 08:19
Flat Medical joins the Stay Connected(R), the International Organization for Safer Neuraxial Anesthesia
2022-02-17 21:00
PharmaBlock Appoints Dr. Zhengtian Gu as Senior Vice President of Quality and Regulatory Affairs
2022-02-16 20:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team
2022-02-15 21:00
AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases
2022-02-15 15:05
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by IASO Bio and Innovent
2022-02-14 08:25
Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results
2022-02-12 06:05
1
84
85
86
87
88
165